A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. - Wikidata - awgldk - TriplyDB

A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

http://www.wikidata.org/entity/Q33360400

about

Gallbladder Cancer in the 21st Century.Gastrointestinal cancers in India: Treatment perspective Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer EGFR expression in gallbladder carcinoma in North America.Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan A genetic model for gallbladder carcinogenesis and its dissemination.Chemotherapy and targeted therapy for gall bladder cancer.Guidelines for chemotherapy of biliary tract and ampullary carcinomas Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: a systematic review.Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.Resection after neoadjuvant chemotherapy in advanced carcinoma of the gallbladder: a retrospective study.Current management of gallbladder carcinoma.NCCN clinical practice guidelines in oncology: hepatobiliary cancers Indian Council of Medical Research consensus document for the management of gall bladder cancer.Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review Chemotherapy for advanced cholangiocarcinoma: what is standard treatment?Chemotherapy Compared with Best Supportive Care for Metastatic/Unresectable Gallbladder Cancer: a Non-randomized Prospective Cohort Study.Targeted therapy for biliary tract cancer.Current status of chemotherapy for the treatment of advanced biliary tract cancer.A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer.Early relapse of unresectable gallbladder cancer after discontinuation of gemcitabine monotherapy administered for 5 years in a patient who had complete response to the treatment.Chemotherapy for the biliary tract cancers: moving toward improved survival time.Long-term survival of a recurrent gallbladder carcinoma patient with lymph node and peritoneal metastases after multidisciplinary treatments: a case report.Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival.GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP.Use of gemcitabine-platinum in Indian patients with advanced gall bladder cancer.Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.Surgery and chemotherapy for intrahepatic cholangiocarcinoma.Comparative Study Between Two Treatment Regimens of Cisplatin-5-Fluorouracil and Gemcitabine-Cisplatin in Gallbladder Cancer Patients.Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report.Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer.Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre.Patterns of failure and determinants of outcomes following radical re-resection for incidental gallbladder cancer.Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer.DUSP1 enhances the chemoresistance of gallbladder cancer via the modulation of the p38 pathway and DNA damage/repair system.

P2860

Q26784174-7A25AB57-B55B-4ECF-87B8-DA8066B23591 Q28066052-7A64FFCA-B9D3-4F9B-B1F7-83A93A431B9D Q30300756-8E25AD61-3519-4BF2-A821-55C52455F2E0 Q33242493-91800141-7FCB-439A-8DEC-65D33935F685 Q33371325-2A4FE0C2-433C-47A0-A900-CB081043AEF4 Q33372640-7E516201-9B12-43F3-BE53-01FE66031BE9 Q33372792-5B16834A-68F4-489A-BFBA-708AE2A12DF0 Q33381056-3EBBE643-107C-44E3-84A7-15EA77542BDC Q33390747-9167512F-EB3C-401B-B88F-29F51BDBB14C Q33683102-3AAA8BDD-EE93-4E5E-8108-2A3DC97E54EB Q33977171-8B9BA65C-B4A9-4652-8888-7207ED45D3D6 Q34588361-F9A70F21-96E9-44BF-9C17-5A2D7B1B1A9E Q34858544-25167D9F-EB50-4AEB-B809-EBDF6759C102 Q34982545-930F8B5E-E29C-4F98-AB00-3C4ED24B38F5 Q35547795-9E146979-2653-4420-92A5-2CBE4F9DBEE0 Q35583920-B9B19F28-9C02-4660-959E-A1CAB08A32C8 Q35703937-BC39F372-871C-4F3D-9AC8-F191E3683440 Q35769701-C98454B8-B2A5-4B7D-89F1-51B1CA8ED1D5 Q35871195-EFE285B5-1526-4818-B1A6-4FE68F87E1AF Q36572534-80C6E147-D720-4035-9FC6-6F4195E000FB Q36739970-FE8AF5D2-5254-4658-B63B-CFF8FAE22C4B Q37132750-B5D00E76-DE5D-4D88-B60F-647D6E08BA7C Q37138732-AC68B11C-7E3E-4154-87C8-8786978435A2 Q37196487-ABC84A77-6F05-4827-ACE0-AD91DA0B1254 Q37350761-BED5DEDD-CF66-4502-8D66-EC77D4F75183 Q37983498-1563E6FE-FAAA-46C2-AE8E-CE37E33D587F Q38372400-5BE567FF-80F1-4CCA-AF10-AB00E9D6A566 Q38735122-6AA6118B-DDA8-4B85-969E-47EF2C603431 Q38858942-6F4E0B4F-2374-4704-88C1-F7B6D6D9635F Q39022553-C85733BC-D5B4-49E6-8DE5-A931D723036B Q39313846-1F36479A-AB78-4005-83A3-D38754F8E406 Q41140456-A92971C3-6403-43BA-904A-2ED186D6E10C Q42125223-17D6C3C6-716E-44FA-B164-AE52A6A729C7 Q42202283-C5551298-CB88-4BA5-9A84-1FEBA714B240 Q44488107-E178B26B-0E88-475A-8D3E-DA69B9DD7650 Q46941755-2A4ECD29-C9F9-4CD8-AD80-FDE0EDFE5B3F Q47404627-0FE16F27-682C-4CB1-9FB0-B5D8BEAB2C3E Q50186839-D3C2D46F-0D12-4990-AE13-9BE897549AAE Q52866427-E5F7C972-7292-4C9A-A84E-7C38DED59D13 Q55608156-2D52E51F-99AE-4990-8312-289E1534E3CF

P2860

A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.

http://www.wikidata.org/entity/Q33360400

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

A phase II study of gemcitabin ...... esectable gall bladder cancer.

@ast

A phase II study of gemcitabin ...... esectable gall bladder cancer.

@en

type

label

A phase II study of gemcitabin ...... esectable gall bladder cancer.

@ast

A phase II study of gemcitabin ...... esectable gall bladder cancer.

@en

prefLabel

A phase II study of gemcitabin ...... esectable gall bladder cancer.

@ast

A phase II study of gemcitabin ...... esectable gall bladder cancer.

@en

P1433

Q33360400-6E268EC9-8B8F-4D60-967B-F60F395790CB

P1476

Q33360400-6948C380-90AA-4B2C-9F0A-78C5D11C6C42

P2093

Q33360400-2203CB4B-5CDF-454E-B4D4-5D6E528DEF18

Q33360400-46D3284E-D1DE-4382-B1F8-6E6E8EEB2004

Q33360400-6EA3684B-81D5-4A21-92F9-4ED376C3B7E1

Q33360400-79CD6D17-9329-451E-8808-4B0381CD4870

Q33360400-7F148EDC-EF14-4782-94DB-148BDEC77944

Q33360400-B3C6E0D1-BAE6-4A1C-8406-6B21D1DB6771

Q33360400-CDC66B5F-251F-4522-9FDF-F5CC88BE1DC5

P2860

Q33360400-034D76EF-F88E-42DE-94FF-D295A32FCAA3

Q33360400-08BA057E-5845-4243-ABCF-9E681EB37D1A

Q33360400-0A570536-1C77-4CC7-B7CE-76708C453159

Q33360400-3EB7BE95-2309-4116-A90F-0BD97C5DB969

Q33360400-4D534687-80E5-462A-852C-54BCB6F0F8C5

Q33360400-4F8B2B40-422D-494C-9343-2EF243CAECE4

Q33360400-72D727B8-FF62-4F11-8100-CDE6BAE98A26

Q33360400-83AB4DBC-5E8B-4A80-AC0B-4C6326BA012A

Q33360400-900473E3-D667-4604-BA45-37519944C13C

Q33360400-E3FA647A-C498-41CB-A1AF-CF0959F5AB10

P2888

Q33360400-8F7D7258-27AF-4822-A231-B3ECCFE58CDF

P304

Q33360400-DFC9F7E2-C8A1-4087-9F04-69CC903B4080

P31

Q33360400-076EB124-5618-4C50-98E6-A120998F432B

P356

Q33360400-4A04C1CF-35D9-490B-88DE-CE2B33999ADB

P407

Q33360400-E9ECFF26-74BE-4659-9D3F-20BBE4F34C05

P433

Q33360400-21250078-AA9D-4C01-A003-6389296B55FB

P478

Q33360400-9B212467-C0DE-4AD7-975C-2D7909A984A8

P577

Q33360400-E50AFF71-FDFD-4586-ABD6-F6C8D12A4D8E

P5875

Q33360400-6B78C1F9-16DF-4539-B01E-2B615F0088C7

P6179

Q33360400-CB5CA639-D60F-44D7-BE90-EC9A91CE8BF7

P698

Q33360400-EA322A74-A457-48DB-AE86-E1657355AB06

P921

Q33360400-76721599-6D2C-4A60-9D82-E021F575B95C

P932

Q33360400-6688360D-7632-41FE-A9BC-268E974F247A

P356

P1433

British Journal of Cancer

P1476

A phase II study of gemcitabin ...... esectable gall bladder cancer.

@en

P2093

B S Awasthy

http://www.w3.org/2001/XMLSchema#string

D C Doval

http://www.w3.org/2001/XMLSchema#string

J Fuloria

http://www.w3.org/2001/XMLSchema#string

J S Sekhon

http://www.w3.org/2001/XMLSchema#string

S Gupta

http://www.w3.org/2001/XMLSchema#string

S K Gupta

http://www.w3.org/2001/XMLSchema#string

V K Shukla

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2001

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.

Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer.

Biliary tract cancers.

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.

Review of gemcitabine in biliary tract carcinoma.

Chemotherapy in biliary tract carcinomas: results in India.

Biliary tract cancer: our experience with gemcitabine treatment.

Activity of gemcitabine in patients with advanced pancreatic carcinoma. A review.

Interaction between cisplatin and gemcitabine in vitro and in vivo.

P2888

P304

1516-1520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601736

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8620401

http://www.w3.org/2001/XMLSchema#string

P6179

1016846770

http://www.w3.org/2001/XMLSchema#string

P698

15083178

http://www.w3.org/2001/XMLSchema#string

P921

P932

2409709

http://www.w3.org/2001/XMLSchema#string